Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the COVID-19 pandemic, as well as food safety and quality assurance in the food supply chain—has announced a new partnership with a leader in the aquaculture farming of Atlantic Salmon in Norway.
The Tucson-based company will work with Pure Norwegian Seafood AS to develop multi-spectral instruments based on Lightsense’s patented Enhanced Photodetection Spectroscopy technology for detection of bacterial pathogens in salmon processing. Bacterial pathogens can result in discarding large quantities of salmon products with a severe financial impact.
Lightsense EPS Spectroscopy.
“We are very excited to partner with Lightsense Technology with their innovative multi-spectral solution for pathogen detection and believe that together we can bring a significant improvement to salmon processing and the aquaculture industry,” said Eldar Henden, CEO of Pure Norwegian Seafood AS.
Lightsense’s EPS technology has been shown to provide unique benefits in a recent research project sponsored by the U.S. Department of Defense, which demonstrated that EPS technology can rapidly detect and identify coronaviruses (including those causing COVID-19) in human saliva, as well as detecting bacterial pathogens, including in aqueous solutions.
“We are pleased to team with Pure Norwegian Seafood, a leader in marine aquaculture, to bring our combined unique and valuable insights to this important emerging area for protecting and enhancing our food supply via early pathogen detection,” said Terje Skotheim, founder and CEO of Lightsense Technology. “This is the start of a long but rewarding path toward truly breakthrough solutions that that can help make our food supply safer and more economical, by providing better control over these ever-emerging complex biological risks.”